An implantable electrical stimulation device for the treatment of patients with spinal cord injuries will be available commercially following approval from the US Food and Drug Administration (FDA).
The US manufacturer, Biocontrol Technology Inc, makes the functional electrical stimulator (FES) which will be marketed by NeuroControl Corp, based in Cleveland, Ohio, under the name of the NeuroControl Freehand System.
The Freehand is surgically implanted beneath the skin to replace damaged or severed nerves and stimulate muscles through electrodes by restoring lost motor functions such as hand-grasping and arm movement. The company expects sales of the device to …
The MedStream Programmable Infusion System, which is implanted in the abdomen, is already approved in Europe and will be rolled out in a phased launch for the U.S. market. The pump is about 3 inches in diameter and about 1-inch thick, and is attached to the SureStream Catheter that transports the drug into the spinal canal. Doctors use a computerized control unit to wirelessly deliver correct drug dosage and rate of flow for each patient.
ОтветитьУдалитьRead more: http://medcitynews.com/2012/08/subsidiary-of-depuy-synthes-receives-fda-approval-for-implantable-device-that-treats-spasticity/#ixzz2OfFgWGBS
automateandvalidate